gebhart/patrepeval huggingface dataset:
Solid hydrogen target for laser driven proton acceleration (2015)

The development of very high power lasers opens up new horizons in various fields, such as laser plasma acceleration in Physics and innovative approaches for proton therapy in Medicine. Laser driven proton acceleration is commonly based on the so-called Target Normal Sheath Acceleration (TNSA) mechanisms: a high power laser is focused onto a solid target (thin metallic or plastic foil) and interact with matter at very high intensity, thus generating a plasma; as a consequence “hot” electrons are produced and move into the forward direction through the target. Protons are generated at the target rear side, electrons try to escape from the target and an ultra-strong quasi-electrostatic field (~1TV/m) is generated. Such a field can accelerate protons with a wide energy spectrum (1-200 MeV) in a few tens of micrometers. The proton beam characteristics depend on the laser parameters and on the target geometry and nature. This technique has been validated experimentally in several high power laser facilities by accelerating protons coming from hydrogenated contaminant (mainly water) at the rear of metallic target, however, several research groups are investigating the possibility to perform experiments by using “pure” hydrogen targets. In this context, the low temperature laboratory at CEA-Grenoble has developed a cryostat able to continuously produce a thin hydrogen ribbon (from 40 to 100 microns thick). A new extrusion concept, without any moving part has been carried out, using only the thermodynamic properties of the fluid. First results and perspectives are presented in this paper.
OROGASTRIC CHALLENGE OF RABBITS WITH HUMAN ENTEROTOXIGENICESCHERICHIA COLI (ETEC) STRAINS THAT ADHERE TO RABBIT BRUSH BORDERSIN VITRO (1998)

114 Background: ETEC infection is a significant cause of infant morbidity and mortality in developing countries. Progress in human enterotoxigenic E. coli vaccine development is hampered by the lack of a convenient animal model of infection. Current animal models are either impractical (using livestock) or require surgery. The natural rabbit pathogen RDEC-1 is an excellent model of an enteroadherentE. coli infection but causes disease by an attaching and effacing lesion rather than by an enterotoxin. Previously, we demonstrated that human ETEC strains bearing the adherence factors (pili) CS3, PCF0159, and PCF0166 bound to rabbit intestinal brush borders invitro. We postulated that ETEC strains bearing these adherence factors would bind invivo and cause diarrheal disease in rabbits. Methods: Suspensions composed of three piliated ETEC strains bearing CS3, PCF0159, and PCF0166 or of non-piliated paired mutants(109 CFU of each strain) were orogastrically administered to rabbits. Animals were monitored daily for shedding of organisms, weight change, and signs of clinical illness. Animals were sacrificed after 1 week and colony forming units of E. coli in the cecum determined. Piliated organisms from cecal contents were detected by colony immunoblot. Rabbits administered nalidixic acid resistant RDEC-1 (109 CFU) served as a colonization control. Results: All animals remained healthy and gained weight after challenge.TableThere were no significant differences in initial weights or weight changes between groups. Strains expressing CS3 and PCF0159 were isolated from cecal contents. Rabbits that received RDEC-1 had significantly (p<0.01) higher colony counts in the cecum than either of the ETEC-challenged groups. Small intestine brush border preparations from 2 challenged rabbits confirmed binding activity for piliated organisms. Conclusions: While colonization did occur, binding of human ETEC to rabbit intestinal brush borders invitro was not a predictor of diarrheal disease with invivo challenge. Colonization with the natural rabbit pathogen was more successful than with any of the human ETEC strains. The ETEC strain expressing CS3 colonized the cecum better than a PCF0159 bearing strain.
Differentiable solver for time-dependent deformation problems with contact (2022)

We introduce a general differentiable solver for time-dependent deformation problems with contact and friction. Our approach uses a finite element discretization with a high-order time integrator coupled with the recently proposed incremental potential contact method for handling contact and friction forces to solve ODE- and PDE-constrained optimization problems on scenes with complex geometry. It supports static and dynamic problems and differentiation with respect to all physical parameters involved in the physical problem description, which include shape, material parameters, friction parameters, and initial conditions. Our analytically derived adjoint formulation is efficient, with a small overhead (typically less than 10% for nonlinear problems) over the forward simulation, and shares many similarities with the forward problem, allowing the reuse of large parts of existing forward simulator code. We implement our approach on top of the open-source PolyFEM library and demonstrate the applicability of our solver to shape design, initial condition optimization, and material estimation on both simulated results and physical validations.
Laser Treatment of Tattoos: Basic Principles (2017)

Tattooing has become very popular worldwide during the past decades, and millions of people have one or many tattoos at different anatomical sites. The color of tattoos is mainly black, followed by red, green, blue, and other colors. A part of the tattooed people regret tattooing or have permanent problems with tattoos and therefore seek for tattoo removal. Tattoos consist of solid pigment particles in the skin. Thus, tattoo removal requires fragmentation of these permanently incorporated particles. The gold standard of tattoo removal is laser therapy. Short light pulses at high intensities are applied to the tattooed skin surface. The laser light penetrates the skin and is selectively absorbed in the pigment particles. The absorbed laser light leads to heat-up and fragmentation of the particles. Due to the complex chemistry of the various tattoo pigments, the efficacy of this fragmentation process is frequently unpredictable. Due to the short and intense pulses, nonlinear effects of light and thermal properties of tattoo particles may play a role, and the assumptions of selective photothermolysis may not reflect the real process of tattoo particle fragmentation as a whole. In case fragmentation occurs, the concentration of pigment particles in the skin decreases, yielding a fading of the tattoo color in the skin. Laser therapy is most effective in black tattoos and less effective for colored tattoos. The rate of side effects is low due to the selectivity of the treatment. Laser light may change the chemistry of the tattoo pigments and hence provoke toxic decomposition products.
Thromboxane inhibition and monocrotaline‐induced pulmonary hypertension in rats (1997)

Monocrotaline (MCT)-induced pulmonary hypertension (PH) is a useful model for the investigation of this disorder in humans. The role of thrombocytes in the genesis of PH has already been addressed; however, the exact mechanism by which they induce PH remains to be elucidated. We investigated the effects of a thromboxane A2 (TXA2) synthase inhibitor (OKY-046) and a TXA2/prostaglandin H2 (PGH2) receptor antagonist (ONO-8809) on the development of MCT-induced PH. A single dose of MCT (60 mg/kg bodyweight; BW) was injected subcutaneously in Wistar rats 24 h after the administration of OKY-046 or ONO-8809. The TXA2 inhibitors were administered by gavage daily for 3 weeks. Urinary excretion of eicosanoids was determined by radioimmunoassay. At the end of the treatment period, the lungs, heart and kidneys were morphologically examined. The per cent medial thickness of the muscular pulmonary arteries (%MT) and the ratio of the right to the left ventricular mass including the septum (RV/LV + S) increased significantly in MCT-treated rats compared with the control rats. The %MT was attenuated by the administration of ONO-8809. Either OKY-046 or ONO-8809 attenuated the increase in RV/LV + S. In addition, both TXA2 inhibitors reduced urinary excretion of 11-dehydro-TXB2, particularly during the early phase of PH, suggesting that platelet aggregation was reduced. These findings suggest that the inhibition of TXA2 by synthase inhibition or receptor antagonism reduces or delays the development of MCT-induced PH in rats, probably by inhibiting platelet aggregation.
p16INK4a Modulates p53 in Primary Human Mammary Epithelial Cells (2006)

p16(INK4a) (p16) and p53 are tumor suppressor genes that are inactivated during carcinogenesis in many tumors. Here we show that p16 gene activity inversely modulates p53 status and function in primary human mammary epithelial cells. Reduced levels of p16 protein stabilize p53 protein through inhibition of proteolytic degradation, and this increase in p53 protein levels enhances the cellular response to radiation, represses proliferation, and transcriptionally activates downstream targets. Stabilization of p53 is mediated through the retinoblastoma/E2F/p14(ARF)/murine double minute-2 pathway. However, we have observed that p16 does not modulate p53 in fibroblasts, indicating a possible cell type-specific regulation of this pathway.
REDUCTION OF BREAST TUMOR BURDEN IN MICE BY A PRENYLATED FLAVONOID, ARTONIN E (2017)

Background Breast cancer is still a leading cause of cancer death among women. Thus, therapeutic alternatives from nature should be explored to lessen this burden. This is vital owing to the common occurrences of resistance in conventional therapies alongside their alarming side effects. Aims This study was carried out to investigate the inhibitory effect of Artonin E in female mice bearing 4T1 mammary tumour. Methods 4T1 cells in 100 mu L PBS were injected into the right mammary fat pad of each female Balb/c mice aged between six to eight weeks. Treatment was commenced when the palpable tumour attained a size of 50-200mm(3). The treatment groups included Artonin E, at dosages of 25mg/kg, 50mg/kg and 100mg/kg per oral bi-weekly, 10mg/kg of paclitaxel weekly and 5 percent tween 20 biweekly. Tumour volume and body weight changes were recorded at the staging day and then twice every week throughout the study period. At the end of the study, the vital tissues were collected for histopathologcal assessment and blood samples were taken for serum biochemical analyses. Results From the results, the group treated with either 50mg/kg or 100mg/kg of Artonin E showed a significant (p<0.05) reduction in tumour volume. Artonin E delayed quadruple tumour growth by more than five days in comparison to the untreated control group. Histopathology and biochemical analysis revealed no toxicity in the dosages of artonin E used in this study. Secondary tumour, which had metastasized to distant organs were seen to reduce upon treatment with Artonin E. Conclusion With the capacity to reduce in vivo tumour growth, Artonin E has a great prospect to be developed into an anticancer agent.
Analysis of Refractive Error and Corneal Asphericity in Elementary School Students in Ilsan City (2008)

1 2 2 1 1 , 2 : , , . : 56 111 , (eccentricity) , , , ,
Aurora Multikilojoule KrF Laser System Prototype for Inertial Confinement Fusion (1987)

Aurora is the Los Alamos National Laboratory short-pulse, high-power, KrF laser system. It serves as an end-to-end technology demonstration for large-scale ultraviolet laser systems of interest for short wavelength, inertial confinement fusion (ICF) investigations. The system is a prototype for using optical angular multiplexing and serial amplification by large electron-beam-driven KrF laser amplifiers to deliver stacked, 248-nm, 5-ns duration multikilojoule laser pulses to ICF targets using an ∼1-km-long optical beam path.The entire Aurora KrF laser system is described and the design features of the following major system components are summarized: front-end lasers, amplifier train, multiplexer, optical relay train, demultiplexer, target irradiation apparatus, and alignment and controls systems.
The Single Point of Failure (2011)

The patent system is just one example of how government institutions create single points of failure by concentrating decision-making power in the hands of the few, whether legislators in Congress, cabinet officials in the executive branch, or bureaucrats in agencies. Administrative practices are constructed around the belief that government professionals know best how to translate broad legislative mandates into specific regulatory decisions in the public interest. Governance, the theory goes, is best entrusted to a bureaucracy operating at one removed from the pressure of electoral politics and the biased influence of the public at large
Applications and failure modes of percutaneous devices: A review (1984)

Percutaneous devices (PD) are designed to serve a variety of clinical and biomedical research purposes. Characteristically they are objects that permanently penetrate through a defect in the skin. The histological aspects of the implant skin interfacial reactions are reviewed in this article. A short description is presented of common applications of PDs. The five presently identified interfacial failure modes are described histologically with the aid of schematic drawings. These failure modes are marsupialization, permigration , avulsion, infection, alone or in combination. Single or multiple etiological factors may be responsible for these failure modes. These factors can be surgically created skin defects around the penetrating foreign implant, epidermal healing characteristics that prevent the formation of a suitable seal at the implant-skin interface and mechanical forces that may disrupt dermal attempts to seal the interface. Eventually the interface becomes infected necessitating removal of the device. Terminology recommended for use in percutaneous device research is indexed and defined.
A CADAVERIC MODEL OF THE THROWING SHOULDER (2005)

Background: It has been speculated that a shift of the throwing arc commonly develops in athletes who perform overhead activities, resulting in greater external rotation and decreased internal rotation caused by anterior capsular laxity and posterior capsular contracture, respectively. Osseous adaptation in the form of increased humeral and glenoid retroversion may provide a protective function in the asymptomatic athlete but cannot explain the pathological changes seen in the shoulder of the throwing athlete. Therefore, the objective of the present study was to examine the biomechanical effects of capsular changes in a cadaveric model. Methods: Ten cadaveric shoulders were tested with a custom shoulder-testing device. Humeral rotational range of motion, the position of the humerus in maximum external rotation, and glenohumeral translations in the anterior, posterior, superior, and inferior directions were measured with the shoulder in 90° of abduction. Translations were measured with the humerus secured in 90° of external rotation. To simulate anterior laxity due to posterior capsular contracture, the capsule was nondestructively stretched 30% beyond maximum external rotation with the shoulder in 90° of abduction. This was followed by the creation of a 10-mm posterior capsular contracture. Rotational, humeral shift, and translational tests were performed for the intact normal shoulder, after anterior capsular stretching, and after simulated posterior capsular contracture. Results: Nondestructive capsular stretching resulted in a significant increase in external rotation (average increase, 18.2° ± 2.1°; p < 0.001), and subsequent simulated posterior capsular contracture resulted in a significant decrease in internal rotation (average decrease, 8.8° ± 2.3°; p = 0.02). There also was a significant increase in anterior translation with the application of a 20-N anterior translational force after nondestructive capsular stretching (average increase, 1.7 ± 0.3 mm, p = 0.0006). The humeral head translated posteroinferiorly when the humerus was rotated from neutral to maximum external rotation. This did not change significantly in association with anterior capsular stretching. Following simulated posterior capsular contracture, there was a trend toward a more posterosuperior position of the humeral head with the humerus in maximum external rotation in comparison with the position in the stretched conditions, although these differences were not significant. Conclusions: A posterior capsular contracture with decreased internal rotation does not allow the humerus to externally rotate into its normal posteroinferior position in the cocking phase of throwing. Instead, the humeral head is forced posterosuperiorly, which may explain the etiology of Type-II superior labrum anterior-to-posterior lesions in overhead athletes. Clinical Relevance: Understanding the biomechanical effects of capsular changes in a cadaveric model of the throwing shoulder may confirm clinical observations and provide insight into the pathological changes often seen in the shoulder of throwing athletes.
Intramolecular C−H Insertion Reactions of Boroxy Fischer Carbene Complexes. Regio- and Diastereoselective Modification of Terpenes (1999)

In-situ-generated dialkylboroxy and diaminoboroxy Fischer carbene complexes lead to oxaborolane or oxazaborolidine derivatives via an intramolecular C−H insertion reaction. Further oxidation of these intermediates yields 1,3-diol or 1,2-amino alcohol derivatives. Diastereoselectivities as high as 99% are reached when starting from boroxy Fischer carbene complexes derived from terpenes, which represents a regio- and diastereoselective modification of this type of natural product. The influence of the Cβ substituents relative to the boron atom on the reaction path is studied, and a mechanism is proposed after identification of an intermediate by NMR. In addition, theoretical calculations show the presence of a boron−metal interaction, which could result as key step to the C−H insertion reaction.
Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. (1986)

The role of platelets in contributing to occlusive coronary artery thrombus formation remains unresolved. A large number of studies have utilized in vitro techniques to study platelet aggregation. This report describes a model of spontaneous in vivo thrombus formation which involves application of current in the left circumflex coronary artery of the dog. Changes in mean coronary blood flow velocity (50% above control) are used to predict the point at which current can be discontinued without interrupting the ongoing process of thrombus formation. Thrombus formation proceeds to total vessel occlusion within 62 +/- 18 minutes after discontinuation of current. Coronary sinus plasma serotonin concentrations are used as an in vivo index of platelet aggregation during thrombus formation. Plasma serotonin levels increased only slightly above baseline levels during initial thrombus formation. Coronary sinus serotonin levels rose markedly after cessation of current, reaching a peak just prior to total vessel occlusion. The marked increase in serotonin concentration observed in the latter stages of thrombus formation strongly suggests that platelet aggregation is a significant factor in the evolution of an occlusive coronary thrombus.
Expression of UGT1A subfamily in rat brain (2016)

UDP-glucuronosyltransferase (UGT) is an enzyme that catalyses a major phase II reaction in drug metabolism. Glucuronidation occurs mainly in the liver, but UGTs are also expressed in extrahepatic tissues, where they play an important role in local metabolism. UGT1A isoforms catalyse the glucuronidation of several drugs, neurotransmitters and neurosteroids that exert pharmacological and physiological effects on the brain. The aim of the current study was to determine UGT1A mRNA expression levels and glucuronidation activities in different regions of the rat brain (namely the cerebellum, frontal cortex, parietal cortex, piriform cortex, hippocampus, medulla oblongata, olfactory bulb, striatum and thalamus). It was found that all UGT1A isoforms were expressed in all the nine regions, but their expression levels differed between the regions. The difference between the regions of the brain where the mRNA levels were highest and those where they were lowest ranged between 2.1- to 7.8-fold. Glucuronidation activities were measured using the UGT substrates such as mycophenolic acid, p-nitrophenol and umbelliferone. Glucuronidation activity was detected in all nine regions of the brain. Activity levels differed between the regions, and were highest in the cerebellum, medulla oblongata and olfactory bulb. Differences in glucuronidation activity between regions with the highest rates and those with the lowest rates ranged from 5.3- to 10.1-fold. These results will contribute to our current understanding of the physiological and pharmacokinetic roles of drug-metabolizing enzymes in the brain. Copyright © 2016 John Wiley & Sons, Ltd.
ChemInform Abstract: 4‐Methyl‐3‐(arylsulfonyl)furoxans: A New Class of Potent Inhibitors of Platelet Aggregation. (1993)

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
High Energy and Average Power Femtosecond Laser for Pumping mid-IR OPAs (2013)

Femtosecond Tm-fiber-laser-pumped Ho:YAG room-temperature CPA system delivering scalable multi-mJ multi-kHz pulses with a bandwidth exceeding 12 nm and the average power of 15 W is developed. Recompressed 530-fs pulses are suitable for broadband WL generation in transparent solids.
Site of Protonation in Methyl Formate (1961)

Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter Facebook Reddit LinkedIn Tools Icon Tools Reprints and Permissions Cite Icon Cite Search Site Citation Gideon Fraenkel; Site of Protonation in Methyl Formate. J. Chem. Phys. 1 April 1961; 34 (4): 1466–1467. https://doi.org/10.1063/1.1731780 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAIP Publishing PortfolioThe Journal of Chemical Physics Search Advanced Search |Citation Search
Structure and function of factor XI (2010)

Factor XI (FXI) is the zymogen of an enzyme (FXIa) that contributes to hemostasis by activating factor IX. Although bleeding associated with FXI deficiency is relatively mild, there has been resurgence of interest in FXI because of studies indicating it makes contributions to thrombosis and other processes associated with dysregulated coagulation. FXI is an unusual dimeric protease, with structural features that distinguish it from vitamin K-dependent coagulation proteases. The recent availability of crystal structures for zymogen FXI and the FXIa catalytic domain have enhanced our understanding of structure-function relationships for this molecule. FXI contains 4 "apple domains" that form a disk structure with extensive interfaces at the base of the catalytic domain. The characterization of the apple disk structure, and its relationship to the catalytic domain, have provided new insight into the mechanism of FXI activation, the interaction of FXIa with the substrate factor IX, and the binding of FXI to platelets. Analyses of missense mutations associated with FXI deficiency have provided additional clues to localization of ligand-binding sites on the protein surface. Together, these data will facilitate efforts to understand the physiology and pathology of this unusual protease, and development of therapeutics to treat thrombotic disorders.